Global Oncology Launches Global Cancer Project Map To Improve Cancer Control Worldwide in Collaboration with NCI
Nonprofit Global Oncology GO) has launched the Global Cancer Project Map, a first-of-its-kind online resource and virtual information exchange for connecting the global cancer community. Developed by GO in collaboration with the National Cancer Institute (NCI) Center for Global Health, the Map enables worldwide access to cancer projects and expertise to improve cancer practices and patient outcomes, especially in low-resource settings.
The Map was unveiled at the Symposium on Global Cancer Research, which is sponsored by NCI, the Consortium of Universities for Global Health (CUGH), and the Dana-Farber Cancer Institute, and is taking place in Boston, MA.
GO developed the Global Cancer Project Map to fill a crucial need for shared resources: According to the World Bank, only 5% of global health funding for cancer is committed to oncology in developing countries. This number stands even though Africa, Asia, and Central and South America account for 60% of the world’s new cancer diagnoses and 70% of the world’s cancer deaths, according to the World Health Organization.
“The Map is an important and innovative step forward in our effort to reduce health disparities and strengthen human capital in underserved areas of the world,” said Michele Barry Director of Stanford University’s Center for Innovation in Global Health. “With cancer rates rapidly increasing in low-resource settings, the Map creates a place where the global cancer community can share and access information that is critical to providing better treatment and care.”
The Global Cancer Project Map is an interactive online database that allows users to search for cancer experts and research projects by country and by cancer type, and then to initiate contact with project principal investigators and programme directors. The Map launched with more than 700 projects spanning six continents. The goal is for the Map to grow exponentially as awareness builds and an online tool is added in late 2015 allowing users to upload projects directly.
The Global Cancer Project Map covers a wide range of projects, from cancer prevention and screening to capacity training, clinical programs and palliative care. Illustrative projects include
• Improving diagnostic accuracy of mammograms for breast cancer in Turkey through new methods
• Preventing arsenic-induced skin cancer in Bangladesh through the study of vitamin E and selenium supplementation
• Creating an early screening test for gastric cancer in Mexico through biomarker identification leading to an early screening test.
According to Dr Ted Trimble, director of NCI’s Center for Global Health, though many dedicated researchers and caregivers are conducting groundbreaking cancer programmes around the world, until today they could not reference the collective knowledge and experiences of their colleagues in one central place. The Global Cancer Project Map has been highly anticipated in the cancer community and will make a significant impact in cancer patient care and global health.
“Before it was difficult or often impossible to find information about cancer projects or experts, especially in resource-limited settings,” said GO co-founder Ami S. Bhatt, Assistant Professor, Stanford University. “The Map now makes it possible to connect colleagues in the global cancer community with a maximum of six clicks of a computer mouse.”
“We have the ambitious goal of providing access to every cancer research, care, and outreach programme in the world through the Map,” said GO co-founder Franklin W. Huang, Instructor at Dana-Farber Cancer Institute and Harvard Medical School. “GO encourages anyone working in cancer to use the Map to get and give valuable information about their projects, contributing to cancer care for patients no matter where they are.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance